Nasdaq Plrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq plrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Plrx Today - Breaking & Trending Today

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Average Recommendation of "Buy" by Analysts

Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) has been assigned an average rating of “Buy” from the nine brokerages that are covering the stock, MarketBeat reports. Nine research analysts have rated the stock with a buy rating. The average 1 year target price among brokers that have updated their coverage on the stock in […] ....

United States , Needham Company , China Universal Asset Management Co , Rathbones Group , Corton Capital Inc , Pliant Therapeutics Inc , Royal Bank , Oppenheimer Co , Quest Partners , Pliant Therapeutics , Get Free Report , Universal Asset Management , Get Free , Pliant Therapeutics Daily , Nasdaq Plrx ,

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Receives Consensus Recommendation of "Buy" from Analysts

Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) has received an average rating of “Buy” from the nine brokerages that are covering the firm, MarketBeat.com reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokerages that have covered the stock in the last year is […] ....

New York , United States , Td Asset Management Inc , Barclays Plc , York State Common Retirement Fund , Pliant Therapeutics Company Profile , China Universal Asset Management Co , Pliant Therapeutics Inc , Needham Company , Royal Bank , York Mellon Corp , Pliant Therapeutics , Get Free Report , New York Mellon Corp , Management Inc , Universal Asset Management , New York State Common Retirement Fund , Get Free , Pliant Therapeutics Daily , Nasdaq Plrx ,

Pliant Therapeutics (NASDAQ:PLRX) Price Target Lowered to $50.00 at Royal Bank of Canada

Pliant Therapeutics (NASDAQ:PLRX – Free Report) had its target price reduced by Royal Bank of Canada from $53.00 to $50.00 in a research report report published on Wednesday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. PLRX has been the subject of a number of other research reports. […] ....

United States , Mike Ouimette , Bernard Coulie , Wells Fargo Company , China Universal Asset Management Co , Securities Exchange Commission , Royal Bank , Quest Partners , Pliant Therapeutics Inc , Acadian Asset Management , Us Bancorp , Needham Company , Pliant Therapeutics , Free Report , General Counsel Mike Ouimette , Exchange Commission , Universal Asset Management , Asset Management , Get Free Report , Pliant Therapeutics Daily , Nasdaq Plrx , Lower Price Target , Royal Bank Of Canada ,

Pliant Therapeutics (NASDAQ:PLRX) Rating Reiterated by HC Wainwright

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research note issued on Wednesday, Benzinga reports. They presently have a $48.00 price target on the stock. HC Wainwright’s price target would suggest a potential upside of 190.56% from the stock’s previous close. Several […] ....

United States , Mike Ouimette , Pliant Therapeutics Inc , Needham Company , Barclays Plc , Royal Bank , Mirae Asset Global Investments Co , Silverarc Capital Management , Wells Fargo Company , Oppenheimer Co , Securities Exchange Commission , Pliant Therapeutics , Get Free Report , Therapeutics Trading Down , Hans Hull , Exchange Commission , General Counsel Mike Ouimette , Asset Global Investments , Capital Management , Partners Asset Management , Pliant Therapeutics Daily , Nasdaq Plrx , Reiterated Rating , Hc Wainwright ,

Rhenman & Partners Asset Management AB Makes New Investment in Pliant Therapeutics, Inc. (NASDAQ:PLRX)

Rhenman & Partners Asset Management AB acquired a new stake in shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm acquired 330,635 shares of the company’s stock, valued at approximately $5,733,000. Rhenman & Partners Asset Management AB […] ....

Nova Scotia , United States , Bernard Coulie , Royal Bank , Fred Alger Management , Blackrock Inc , Needham Company , Wells Fargo Company , Pliant Therapeutics Inc , Pliant Therapeutics Company Profile , Capital International Investors , Pricet Rowe Associates Inc , Partners Asset Management , Pliant Therapeutics , Free Report , Alger Management , Street Corp , Hans Hull , Visit Holdingschannel , Pliant Therapeutics Daily , Nasdaq Plrx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,